Prospective obserbational study of diabetes using new classifications by HLA, SNPs and biomarkers

Prospective obserbational study of diabetes using new classifications by HLA, SNPs and biomarkers - Ehime Genome Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050579

Enrollment

6000

Registered

2023-03-14

Start date

2020-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 1 diabetes mellitus, type 2 diabetes mellitus, metabolic syndrome, cardiovascular diseases, kidney diseases, dementia, sarcopenia, frailty, periodontal disease, cancer, allergic and immunologic diseases, and other diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) About 3000 patients with diabetes: inpatients and outpatients in Ehime university hospital and the affiliated hospitals*, and the residents in Toon city (Ehime, Japan) who are participated in the Toon Genome Study** 2) About 3000 participants without diabetes: the residents in Toon city (Ehime, Japan) who are participated in the Toon Genome Study** * The patients were recruited as a part of the Ehime Study since 1998 ** This study commenced in 2009

Exclusion criteria

Exclusion criteria: 1) Patients who do not consent to the study 2) Patients who are judged inappropriate for the study by a doctor

Design outcomes

Primary

Measure	Time frame
Onset or progression of diabetes mellitus, cardiovascular diseases, kidney diseases, dementia, sarcopenia, frailty, periodontal disease, cancer, allergic and immunologic diseases, and other diseases	—

Countries

Japan

Contacts

Public ContactRyoichi Kawamura

Ehime University Graduate School of Medicine Diabetes and Molecular Genetics

kawamura.ryoichi.me@ehime-u.ac.jp089-960-5647

Outcome results